Abstract 1944: Using patient-derived cancer organoids to determine the effects of the anti-EGFR therapy panitumumab in the presence or absence of KRAS mutation
Year: 2024
Type: conference-abstract
Source: Cancer Research
Institution: University of Wisconsin–Madison
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4393073761
